Reduction of Circulating Soluble FLT-1 Alleviates Preeclampsia-Like Symptoms in a Mouse Model

Journal of Cellular and Molecular Medicine- United Kingdom

doi 10.1111/j.1582-4934.2009.00820.x

Full Text

Abstract

Available in

Date

Authors

Publisher

Wiley

Related search

427: Metformin Decreases Circulating Inflammatory Cytokines in a Mouse Model of Obesity Complicated by sFlt-1-induced Preeclampsia

American Journal of Obstetrics and Gynecology
GynecologyObstetrics
2019English

Prevention of Diabetic Retinopathy by Intraocular Soluble FLT-1 Gene Transfer in a Spontaneously Diabetic Rat Model

International Journal of Molecular Medicine
MedicineGenetics
2007English

Decidual Cox2 Inhibition Improves Fetal and Maternal Outcomes in a Preeclampsia-Like Mouse Model

JCI insight
Medicine
2016English

Soluble FMS-Like Tyrosine Kinase-1 Alters Cellular Metabolism and Mitochondrial Bioenergetics in Preeclampsia

Frontiers in Physiology
Physiology
2018English

Targeting the Phosphorylation Site of MARCKS Alleviates Symptoms of Steroid-Resistant Like Asthma in a Murine Model

British Journal of Pharmacology
Pharmacology
2019English

Gestational Hypoxia Induces Preeclampsia-Like Symptoms via Heightened Endothelin-1 Signaling in Pregnant Rats

Hypertension
Internal Medicine
2013English

Placental Growth Factor, Soluble FMS-Like Tyrosine Kinase 1, Soluble Endoglin, IL-6, and IL-16 as Biomarkers in Preeclampsia

Mediators of Inflammation
ImmunologyCell Biology
2016English

Sirtuin 1 Activation Alleviates Cholestatic Liver Injury in a Cholic Acid-Fed Mouse Model of Cholestasis

Hepatology
MedicineHepatology
2016English

Resveratrol Inhibits Release of Soluble FMS-Like Tyrosine Kinase (sFlt-1) and Soluble Endoglin and Improves Vascular Dysfunction – Implications as a Preeclampsia Treatment

Scientific Reports
Multidisciplinary
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy